Olympus secures FDA clearance for TJF-Q190V duodenoscope

Filed under: Medical Device News | Tags: , , , , ,

Olympus Medical Systems Group has secured clearance from the US Food and Drug Administration (FDA) for its TJF-Q190V duodenoscope with a sterile, disposable distal endcap.

The latest generation duodenoscope from Olympus is said to have integrated advanced features to enhance cleaning and reprocessing of the endoscopy instrument, in order to help in reducing potential device contamination.

The disposable component of the TJF-Q190V duodenoscope is said to help in improving access to the elevator mechanism for easier reprocessing.

Kurt Heine – Group Vice President for Endoscopy at Olympus America said: “Infection prevention is an ongoing mission that we at Olympus are committed to fulfilling, working in partnership with our customers, medical societies, and regulatory authorities to keep patients safe while providing physicians the most advanced tools and technology for accurate and effective diagnosis and treatment.”

Olympus secures FDA clearance for TJF-Q190V duodenoscope

Olympus secures FDA clearance for TJF-Q190V duodenoscope. Photo courtesy of Olympus America.

The sterile, clear, single-use distal endcap cover of the TJF-Q190V duodenoscope can be taken off and thrown out after the procedure.

The TJF-Q190V duodenoscope is said to provide enhanced visualization and access to the distal end to enable manual cleaning and disinfection. It comes with advanced distal-end flushing adaptor to clean the elevator mechanism.

There is also a sealed elevator wire channel port that does not need separate cleaning. Additionally, its water-resistant scope connector is said to lower the risk of fluid ingress.

Dr Ross Segan – Chief Medical Safety Officer at Olympus Corporation of the Americas said: “A goal of our innovation is to expand the capabilities of our physician customers, while making it easier to achieve patient safety standards.

“The further into the body we can go with minimally invasive equipment, the more power we will have to diagnose life-threatening conditions and treat them, which can lead to critical benefits, including reduced costs and improved patient outcomes and satisfaction.”

Related posts

Leave a Reply

Your email address will not be published. Required fields are marked *